AI in Pharma

ai-pharma

Article

Can AI Decode the Gut? : Machine Learning in Microbiome Research

AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical ...

How ML Virtual Screening Is Scaling Cancer Drug Targets?

Mrudula Kulkarni

Other latest pieces about AI in Pharma you may like to read

Can AI Decode the Gut? : Machine Learning in Microbiome Research

AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.

by Dr. Nalini Raghunathan
Pharma Now

How ML Virtual Screening Is Scaling Cancer Drug Targets?

ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.

by Mrudula Kulkarni
Pharma Now

Schrodinger vs. Insilico Medicine: A Comparison Report

Physics vs generative AI for cancer drug design. Schrodinger and Insilico Medicine compared pipeline, deals, and proof.

by Mrudula Kulkarni
Pharma Now

The Top AI Chemistry Platforms Transforming Small Molecule Oncology in 2026

Fewer than 700 of 20,000 human proteins have ever yielded a drug. 5 AI platforms are unlocking oncology's "undruggable" targets.

by Mrudula Kulkarni
Pharma Now

Quantifying the ROI: Do AI Chemistry Platforms Actually Reduce Pharma R&D Costs?

AI drug discovery raised billions in deals. Deloitte's 2026 report found the ROI "hasn't been realized at scale" yet. Here's why.

by Mrudula Kulkarni
Pharma Now